Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

Real-Time Quote
As of Dec 02
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Robust Pipeline Supports 5.5% Dividend Yield
10:34am / GuruFocus News - Paid Partner Content
Tweedy Browne Fund Investment Adviser's Semi-Annual Letter to Shareholders
Nov 28 / GuruFocus News - Paid Partner Content
How to Buy GlaxoSmithKline at a 15% Discount
Dec 02 / TheStreet.com - Paid Partner Content
Glaxo (GSK) Files Regulatory Application for Shingrix in EU
Nov 28 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
Glaxo Nucala Favorable in Rare Vasculitis Disease Study
Nov 24 / Zacks.com - Paid Partner Content
Jeff Auxier Curbs Multiple Positions in 3rd Quarter
Dec 01 / GuruFocus News - Paid Partner Content
3 Potentially Huge Catalysts for Ionis Pharmaceuticals, Inc. in 2017
Nov 23 / MotleyFool.com - Paid Partner Content
Here's the Best Dividend Stock in Big Pharma
Dec 01 / MotleyFool.com - Paid Partner Content
Glaxo Files for COPD Drug; FluLaval Approved for Infants
Nov 22 / Zacks.com - Paid Partner Content
10 Undervalued High-Yield Dividend Stocks Worth Buying Today
Nov 30 / TheStreet.com - Paid Partner Content
Drug and biotech stocks soar on Trump victory
Nov 09 / CNNMoney.com
Merck: Keytruda's Priority Review for New Cancer Indication
Nov 29 / Zacks.com - Paid Partner Content